Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide
Bone Marrow Transplantation, Published online: 05 January 2024; doi:10.1038/s41409-023-02189-9Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 5, 2024 Category: Hematology Authors: Niveditha Ravindra Laura W. Dillon Gege Gui Matthew Smith Lukasz P. Gondek Richard J. Jones Adam Corner Christopher S. Hourigan Alexander J. Ambinder Source Type: research
Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD
Bone Marrow Transplantation, Published online: 05 January 2024; doi:10.1038/s41409-023-02181-3Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 5, 2024 Category: Hematology Authors: Zahra Hudda Amanda Flannery Ashley Teusink-Cross Stella M. Davies Pooja Khandelwal Source Type: research
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Bone Marrow Transplantation, Published online: 04 January 2024; doi:10.1038/s41409-023-02169-zLong-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 4, 2024 Category: Hematology Authors: Olalekan O. Oluwole Edouard Forcade Javier Mu ñoz Sophie de Guibert Julie M. Vose Nancy L. Bartlett Yi Lin Abhinav Deol Peter McSweeney Andre H. Goy Marie Jos é Kersten Caron A. Jacobson Umar Farooq Monique C. Minnema Catherine Thieblemont John M. Timme Source Type: research
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, Published online: 04 January 2024; doi:10.1038/s41409-023-02178-ySeverity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 4, 2024 Category: Hematology Authors: Saurabh Chhabra James H. Jerkins Kathleen Monahan Aniko Szabo Nirav N. Shah Sameem Abedin Lyndsey Runaas Timothy S. Fenske Marcelo C. Pasquini Bronwen E. Shaw William R. Drobyski Wael Saber Anita D ’Souza Binod Dhakal Meera Mohan Walter Longo Mehdi Hama Source Type: research
Oxymorons, wine and haematology
Bone Marrow Transplantation, Published online: 03 January 2024; doi:10.1038/s41409-023-02187-xOxymorons, wine and haematology (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 3, 2024 Category: Hematology Authors: Shaun R. McCann Source Type: research
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
Bone Marrow Transplantation, Published online: 02 January 2024; doi:10.1038/s41409-023-02171-5Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 2, 2024 Category: Hematology Authors: M ónica Cabrero Lucia L ópez-Corral Isidro Jarque F átima de la Cruz-Vicente Estefan ía Pérez- López David Valc árcel Jaime Sanz Ildefonso Espigado Guillermo Ort í Carmen Mart ín- Calvo Javier de la Serna Dolores Caballero Source Type: research
Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation
Bone Marrow Transplantation, Published online: 26 December 2023; doi:10.1038/s41409-023-02185-zRisk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 26, 2023 Category: Hematology Authors: Yuanyuan Zhang Jinzhou Guo Wencui Chen Liang Zhao Xianghua Huang Source Type: research
Role of allogeneic hematopoietic stem cell transplantation in patients with high-risk T-cell lymphoblastic leukaemia/lymphoma: an analysis of clinical outcomes
Bone Marrow Transplantation, Published online: 23 December 2023; doi:10.1038/s41409-023-02182-2Role of allogeneic hematopoietic stem cell transplantation in patients with high-risk T-cell lymphoblastic leukaemia/lymphoma: an analysis of clinical outcomes (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 23, 2023 Category: Hematology Authors: Xiaoting Zhang Yuyang Pang Cong Wei Dan Liang Shaoxin Yang Chong Zhao Rui Huang Lan Deng Source Type: research
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Bone Marrow Transplantation, Published online: 21 December 2023; doi:10.1038/s41409-023-02166-2Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 21, 2023 Category: Hematology Authors: Claire Seydoux Chakradhara Rao Satyanarayana Uppugunduri Michael Medinger Tiago Nava Joerg Halter Dominik Heim Yves Chalandon Urs Schanz Gayathri Nair Nathan Cantoni Jakob R. Passweg Marc Ansari Source Type: research
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor
Bone Marrow Transplantation, Published online: 19 December 2023; doi:10.1038/s41409-023-02162-6Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 19, 2023 Category: Hematology Authors: Junichi Sugita Takashi Kuroha Jun Ishikawa Tetsuya Eto Kentaro Fukushima Isao Yokota Koichi Akashi Shuichi Taniguchi Mine Harada Takanori Teshima Source Type: research
KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis
Bone Marrow Transplantation, Published online: 19 December 2023; doi:10.1038/s41409-023-02175-1KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 19, 2023 Category: Hematology Authors: Tomoyasu Jo Yasuyuki Arai Toshio Kitawaki Naokazu Nakamura Momoko Nishikori Chisaki Mizumoto Junya Kanda Kouhei Yamashita Miki Nagao Akifumi Takaori-Kondo Source Type: research
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study
Bone Marrow Transplantation, Published online: 18 December 2023; doi:10.1038/s41409-023-02168-0Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 18, 2023 Category: Hematology Authors: Philip L. McCarthy Kristopher M. Attwood Xiaojun Liu George L. Chen Hans Minderman Amin Alousi Asad Bashey Robert Lowsky David B. Miklos John Hansen Peter Westervelt Gregory Yanik Edmund K. Waller Alan Howard Bruce R. Blazar Paul K. Wallace Ran Reshef Mar Source Type: research
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, Published online: 16 December 2023; doi:10.1038/s41409-023-02172-4Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 16, 2023 Category: Hematology Authors: Ryu Yanagisawa Hiroaki Koyama Kimikazu Yakushijin Naoyuki Uchida Atsushi Jinguji Wataru Takeda Tetsuya Nishida Masatsugu Tanaka Tetsuya Eto Hiroyuki Ohigashi Kazuhiro Ikegame Ken-ichi Matsuoka Yuta Katayama Yoshinobu Kanda Masashi Sawa Toshiro Kawakita Ma Source Type: research
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy
Bone Marrow Transplantation, Published online: 16 December 2023; doi:10.1038/s41409-023-02176-0Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 16, 2023 Category: Hematology Authors: Samantha El Warrak Mohamed A. Kharfan-Dabaja Madiha Iqbal Mehdi Hamadani Julio Chavez Razan Mohty Source Type: research
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Bone Marrow Transplantation, Published online: 15 December 2023; doi:10.1038/s41409-023-02161-7Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - December 15, 2023 Category: Hematology Authors: Shuichi Ito Atsuro Saito Ayako Sakurai Kenichiro Watanabe Shuhei Karakawa Takako Miyamura Tomoko Yokosuka Hideaki Ueki Hiroaki Goto Hiroshi Yagasaki Mariko Kinoshita Michio Ozeki Norifumi Yokoyama Hirofumi Teranishi Source Type: research
